ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss or no Loss
Condition: Gynaecological Cancers Interventions: Drug: AZD6738; Drug: Olaparib Sponsors: Institute of Cancer Research, United Kingdom; Cancer Research UK; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials